Virbac finalizes minority shares’ acquisition of Globion, an Indian poultry vaccines specialist
July 02 2024 - 10:45AM
Virbac finalizes minority shares’ acquisition of Globion, an Indian
poultry vaccines specialist
On June 21, we finalized the acquisition
of Globion's minority shares, bringing our stake to 100%. As
planned, this transaction follows the acquisition of a 74% majority
stake concluded on November 1, 2023.
Founded in 2005, as a joint venture between
Suguna Group, one of the leading Indian poultry conglomerates, and
Lohmann Animal Health, a German poultry vaccines specialist,
Globion has developed robust know-how and expertise in the
development, manufacturing and commercialization of live and
inactivated vaccines targeting a large array of avian
pathogens.
Globion is based in Hyderabad where its
industrial and R&D facilities employ around 120 full-time
employees and generated approximately €12 million of revenue in
2023.
A lifelong commitment to animal
healthAt Virbac, we provide innovative solutions to
veterinarians, farmers and animal owners in more than 100 countries
around the world. Covering more than 50 species, our range of
products and services enables us to diagnose, prevent and treat the
majority of pathologies. Every day, we are committed to improving
the quality of life of animals and to shaping the future of animal
health together.
Contacts presse - Agence Libre
MullenloweKeïsha Tema –
k.tema@libremullenlowe.fr –
07 63 18 59 03Anne Da Silva Passos
– a.dasilvapassos@libremullenlowe.fr
– 07 60 53 99 28
- VIRBAC PR - Finalization of the Globion acquisition- 02 07
2024
Virbac (EU:VIRP)
Historical Stock Chart
From Nov 2024 to Dec 2024
Virbac (EU:VIRP)
Historical Stock Chart
From Dec 2023 to Dec 2024
